Preferred Label : brexpiprazole;

MeSH synonym : 7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one;

UNII : 2J3YBM1K8C;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/rxulti
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
brexpiprazole
brexpiprazole
drug approval
europe
schizophrenia
adult
administration, oral
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
antipsychotic agents
antipsychotic agents
drug evaluation, preclinical
thiophenes
quinolones
thiophenes
quinolones

---
Summary Basis of Decision (SBD) for Rexulti
Brexpiprazole 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg tablets, oral
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00353
2017
false
false
false
Canada
French
drug information
brexpiprazole
brexpiprazole
drug approval
canada
treatment outcome
schizophrenia
antipsychotic agents
adult
aged
brexpiprazole
antipsychotic agents
tablets
administration, oral
thiophenes
quinolones
thiophenes
quinolones

---
Nous contacter.
17/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.